title: Heparan sulfate proteoglycans in the human sclerosing and scarring kidney. Changes in heparan sulfate moiety.
authors.affiliation: Branch Hospital, Nagoya University, School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Morita
authors.forename: G
authors.initials: G
authors.lastname: David
authors.forename: A
authors.initials: A
authors.lastname: Mizutani
authors.forename: T
authors.initials: T
authors.lastname: Shinzato
authors.forename: H
authors.initials: H
authors.lastname: Habuchi
authors.forename: K
authors.initials: K
authors.lastname: Maeda
authors.forename: K
authors.initials: K
authors.lastname: Kimata
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D001665:Binding Sites; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D005355:Fibrosis; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism*; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D007124:Immunoenzyme Techniques; D007668:Kidney / Q000378:metabolism / Q000473:pathology*; D011509:Proteoglycans / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D016222:Fibroblast Growth Factor 2; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate; D011509:Proteoglycans